Vitamin D insufficiency in CLL: a modifiable prognostic factor?
作者信息
Parikh Sameer A, Shanafelt Tait D
机构信息
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
出版信息
Blood Adv. 2024 Jul 23;8(14):3838-3839. doi: 10.1182/bloodadvances.2024013428.
Abstract
摘要
相似文献
1
Vitamin D insufficiency in CLL: a modifiable prognostic factor?慢性淋巴细胞白血病中的维生素D缺乏：一个可改变的预后因素？
Blood Adv. 2024 Jul 23;8(14):3838-3839. doi: 10.1182/bloodadvances.2024013428.
2
Serum 25-hydroxyvitamin D Insufficiency in B-Chronic Lymphoid Leukemia at the Time of Disease Presentation in Pakistan.巴基斯坦B细胞慢性淋巴细胞白血病发病时血清25-羟基维生素D不足情况
Asian Pac J Cancer Prev. 2015;16(14):5983-6. doi: 10.7314/apjcp.2015.16.14.5983.
3
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).维生素 D 不足可预测早期慢性淋巴细胞白血病 (CLL) 患者的首次治疗 (TFT) 时间。
Leuk Res. 2012 Apr;36(4):443-7. doi: 10.1016/j.leukres.2011.10.004. Epub 2011 Nov 1.
4
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.维生素 D 不足与慢性淋巴细胞白血病的预后。
Blood. 2011 Feb 3;117(5):1492-8. doi: 10.1182/blood-2010-07-295683. Epub 2010 Nov 3.
5
Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia.维生素D补充剂对慢性淋巴细胞白血病患者的疗效及安全性
Postepy Hig Med Dosw (Online). 2016 May 21;70(0):534-41. doi: 10.5604/17322693.1202482.
6
Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.维生素D不足的淋巴瘤或慢性淋巴细胞白血病患者维生素D替代策略的验证
Blood Cancer J. 2017 Feb 3;7(2):e526. doi: 10.1038/bcj.2017.9.
7
Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies.血清25-羟维生素D[25(OH)D]浓度对淋巴系统恶性肿瘤患者的预后影响
Hematology. 2013 Jan;18(1):20-5. doi: 10.1179/1607845412Y.0000000025. Epub 2012 Sep 12.
8
C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation.维生素D补充后慢性淋巴细胞白血病患者血清中C-C基序配体11减少。
Hematology. 2016 Jul;21(6):343-50. doi: 10.1080/10245332.2016.1142162. Epub 2016 Mar 1.
9
Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.糖尿病与慢性淋巴细胞白血病患者预后不良相关：一项倾向评分匹配分析。
Cancer Res Treat. 2020 Jan;52(1):189-206. doi: 10.4143/crt.2019.122. Epub 2019 Jul 1.
10
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.正电子发射断层扫描-计算机断层扫描在慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者管理中的应用
Leuk Lymphoma. 2014 Sep;55(9):2079-84. doi: 10.3109/10428194.2013.869801. Epub 2014 Feb 17.
本文引用的文献
1
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment.维生素 D 补充剂可使早期慢性淋巴细胞白血病患者的首次治疗时间延长。
Blood Adv. 2024 Jul 23;8(14):3840-3846. doi: 10.1182/bloodadvances.2023011458.
2
Vitamin D and potential effects on cancers: a review.维生素 D 及其对癌症的潜在影响：综述。
Mol Biol Rep. 2024 Jan 25;51(1):190. doi: 10.1007/s11033-023-09111-y.
3
A Systematic Review Assessing the Impact of Vitamin D Levels on Adult Patients with Lymphoid Malignancies.一项评估维生素 D 水平对成人淋巴恶性肿瘤患者影响的系统评价。
Curr Oncol. 2023 Apr 20;30(4):4351-4364. doi: 10.3390/curroncol30040331.
4
High-dose vitamin D supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial.复发缓解型多发性硬化症的大剂量维生素D补充治疗：一项随机临床试验
EClinicalMedicine. 2023 Apr 13;59:101957. doi: 10.1016/j.eclinm.2023.101957. eCollection 2023 May.
5
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).维生素 D 不足可预测早期慢性淋巴细胞白血病 (CLL) 患者的首次治疗 (TFT) 时间。
Leuk Res. 2012 Apr;36(4):443-7. doi: 10.1016/j.leukres.2011.10.004. Epub 2011 Nov 1.
6
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.维生素 D 不足与慢性淋巴细胞白血病的预后。
Blood. 2011 Feb 3;117(5):1492-8. doi: 10.1182/blood-2010-07-295683. Epub 2010 Nov 3.
7
Vitamin D deficiency in adults: when to test and how to treat.成人维生素 D 缺乏：何时检测及如何治疗。
Mayo Clin Proc. 2010 Aug;85(8):752-7; quiz 757-8. doi: 10.4065/mcp.2010.0138.
8
Vitamin D deficiency.维生素D缺乏症
N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
9
The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro.维生素D3类似物EB1089通过一种不依赖p53的机制诱导细胞凋亡，该机制涉及体外B细胞慢性淋巴细胞白血病细胞中p38丝裂原活化蛋白激酶的激活和细胞外信号调节激酶活性的抑制。
Blood. 2003 Apr 1;101(7):2454-60. doi: 10.1182/blood-2002-07-1984. Epub 2002 Nov 21.
10
Photosynthesis of previtamin D3 in human skin and the physiologic consequences.人皮肤中维生素D3原的光合作用及其生理后果。
Science. 1980 Oct 10;210(4466):203-5. doi: 10.1126/science.6251551.
Zotero 插件